{"disease":{"id":"treatment-resistant-bipolar-disorder","name":"treatment resistant bipolar disorder"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04226963","title":"A Naturalistic Study of Ketamine for Treatment Resistant Mood Disorders","phase":"","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Medical University of Gdansk","has_results":false},{"nct_id":"NCT05870501","title":"Synaptic Imaging and Network Activity in Treatment Resistant Depression","phase":"NA","overall_status":"COMPLETED","enrollment_count":56,"lead_sponsor_name":"King's College London","has_results":false},{"nct_id":"NCT07047651","title":"Τhe Combination of Pharmacotherapy With RECOVERYTRSGR and RECOVERYTRSBDGR.","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Dr. Stavroula Rakitzi","has_results":false},{"nct_id":"NCT02882711","title":"The UTHealth Ketamine Project","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":10,"lead_sponsor_name":"The University of Texas Health Science Center, Houston","has_results":true},{"nct_id":"NCT06431386","title":"Behavioural Activation Therapy and Esketamine for Resistant Depression","phase":"NA","overall_status":"TERMINATED","enrollment_count":6,"lead_sponsor_name":"The Royal's Institute of Mental Health Research","has_results":false},{"nct_id":"NCT02757521","title":"Nitrous TRD Bipolar Depression","phase":"EARLY_PHASE1","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Washington University School of Medicine","has_results":true}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}